Notably, mice injected with XIAP-siRNA exhibited more serious pathological changes and had a higher risk of developing NAFLD than did mice injected with ItsiRNA/HFD. The gene discussed is XIAP; the disease is metabolic dysfunction-associated steatotic liver disease.